Integrated Diagnostics Holdings PLC

4 May 2023

Integrated Diagnostic Holdings plc (the "Company")

Annual Financial Report & Notice of AGM

4 May 2023

Following the Company's announcement of Final Results issued on 6 April 2023, Integrated Diagnostics Holdings plc (the 'Company') has today posted its Annual Accounts for the year ended 31 December 2022 and Annual General Meeting ("AGM") Circular to shareholders.

In accordance with Disclosure Guidance and Transparency Rules 6.3.5 the Annual Accounts are available on the Company's website ( www.idhcorp.com ). Furthermore, in accordance with Listing Rule 14.3.6, each above mentioned document are available for inspection via the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

The Company will be holding its Annual General Meeting on Tuesday, 30 May 2023 at 3pm (BST) / 4pm (EET) at the offices of Actis, 2 More London Riverside, London SE1 2JT.

If you are unable to attend the AGM but would like to vote on the Resolutions, kindly request to submit your proxy vote online at www.signalshares.com or in accordance with the instructions set out in note 2 of the Explanatory Notes to the Notice of the AGM which can be found on the Company's website.

Shareholders wishing to access the dial-in facility or submit questions are asked to email nancy.fahmy@idhcorp.com by close of business on Monday, 22 May 2023.

For further information please contact:

Integrated Diagnostic Holdings plc	+20(0)12 2255 7445
Nancy Fahmy Investor Relations Director

Company Secretary: Link Company Matters Limited	IDHLondon@linkgroup.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END